NovoPedics Overview

  • Founded
  • 2013
  • Status
  • Private
  • Employees
  • 4
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $500K
Latest Deal Amount
  • Investors
  • 1

NovoPedics General Information


Developer of an implantable medical device designed to restore mobility in patients suffering from severe meniscal knee injuries. The company's device is a biodegradable polymer, fiber-reinforced scaffold for total meniscal replacement of damaged meniscal tissue with a patented fiber-reinforced design similar to the native meniscus and can be attached to both soft tissues and bones, enabling surgeons to offer advanced treatment in total meniscus replacement surgery.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Primary Office
  • 120 Albany Street
  • Tower 2, Suite 850
  • New Brunswick, NJ 08901
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

NovoPedics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 18-Apr-2013 $500K 00000 Completed Generating Revenue
To view NovoPedics’s complete valuation and funding history, request access »

NovoPedics Executive Team (3)

Name Title Board Seat Contact Info
Kevin Weadock Ph.D Chief Operating Officer
Charles Gatt MD Co-Founder, President & Board Member
Michael Dunn Ph.D Co-Founder, Secretary, Treasurer & Board Member
To view NovoPedics’s complete executive team members history, request access »

NovoPedics Board Members (4)

Name Representing Role Since
Charles Gatt MD NovoPedics Co-Founder, President & Board Member 000 0000
James Golubieski Foundation Venture Capital Group Board Member 000 0000
Michael Dunn Ph.D NovoPedics Co-Founder, Secretary, Treasurer & Board Member 000 0000
Vincent Smeraglia Self Board Member 000 0000
To view NovoPedics’s complete board members history, request access »

NovoPedics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NovoPedics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Foundation Venture Capital Group Venture Capital Minority 000 0000 000000 0
To view NovoPedics’s complete investors history, request access »